Key result
At 15 months, 39% of stroke or TIA patients with atrial fibrillation were nonadherent to recommended oral anticoagulation, driven by patient fears and physician concerns about functional status.
Cohort (n=139)
No
A high rate of nonadherence to oral anticoagulation in stroke patients with atrial fibrillation is driven by patient fears of side effects and physician concerns regarding functional status, highlighting the importance of in-hospital initiation.
No takes yet. Share an insight, caveat, or question.
Nonadherence to anticoagulation in AF stroke patients warrants attention to fears and functional concerns; leaves open optimal interventions pending prospective trials.
Gumbinger et al. (2015) conducted a cohort in Acute ischemic stroke or transient ischemic attack (TIA) and atrial fibrillation (n=139). Oral anticoagulation (OAC) was evaluated on Nonadherence to OAC therapy at follow-up. At 15 months, 39% of stroke or TIA patients with atrial fibrillation were nonadherent to recommended oral anticoagulation, driven by patient fears and physician concerns about functional status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: